News

• Petition on the role of In Silico Trials

  Almost 400 researchers signed the petition to promote the adoption of In Silico Trials through EMA’s strategy on Regulatory Science to 2025.

  -Read more-

• Peter Coveney has been elected to membership of the Academia Europaea

  Based on his outstanding achievements as a scientist, the coordinator of the running CompBioMed project, Prof Peter Coveney has been invited to join the Academia Europaea

  -Read more-

• A new book on Multiscale Mechanobiology in Tissue Engineering

  This book recently published by Springer focuses on the mechanobiological principles in tissue engineering with a particular emphasis on the multiscale aspects of the translation of mechanical forces from bioreactors down to the cellular level.

  -Read more-

• In silico oncology en route to clinical translation

  The VPHi members, Prof Norbert Graf and Prof Georgios Stamatakos, have joined forces to validate the Nephroblastoma Oncosimulator and design the next critical steps of its clinical translation procedure.

  -Read more-

• Dassault enhances clinical tech with Medidata acquisition

  Dassault Systèmes acquired U.S.-based Medidata, major player in information technologies for clinical trials, for $5.5 billion. This represents to date the largest buyout in the emerging area of in silico medicine and in silico trials and a significant milestone to address the complexity of developing personalied medicine and patient-centric experiences.

  -Read more-

• European Strategy for High Performance Computing

  On the 17 June 2019, the European Commission published a presentation explaining why they indicated High Performance Computing (HPC) as a priority area for investments, and showing some concrete examples.

  -Read more-